21 October 2025 : Original article
Low-Dose r-ATG vs Basiliximab in Low-Risk Living-Donor Kidney Transplantation: Outcomes in Acute Rejection, Graft Function, and Infections
Nam HoDOI: 10.12659/AOT.949942
Ann Transplant 2025; 30:e949942
Figure 1 Flow chart of the study. Created using Microsoft Word (version 2019; Microsoft Corp., Redmond, WA, USA).






